SCHEMBL6856928

SCHEMBL6856928

C[Si](C)(C)C[Si](C)(C)CCCCCCCCOc1ccc(-c2ncc(OCCCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)F)cn2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.34
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HDAC1 Q13547 3/20 0.30
HDAC6 Q9UBN7 3/20 0.30
HDAC5 Q9UQL6 3/20 0.30
HDAC3 O15379 2/20 0.30
HDAC4 P56524 2/20 0.30
HDAC7 Q8WUI4 2/20 0.30
HDAC2 Q92769 2/20 0.30
HDAC10 Q969S8 2/20 0.30
HDAC11 Q96DB2 2/20 0.30
HDAC8 Q9BY41 2/20 0.30
HDAC9 Q9UKV0 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6858745 1.00 NPC1 (0.38) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6854356 1.00 NPC1 (0.38) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6535039 0.94 NPC1 (0.36) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6534705 0.89 NPC1 (0.39) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6856704 0.88 NPC1 (0.41) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6534955 0.85 NPC1 (0.45) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6534787 0.84 NPC1 (0.44) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6535033 0.84 NPC1 (0.44) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6850486 0.81 NPC1 (0.55) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10
SCHEMBL6534731 0.80 NPC1 (0.38) NPC1RAB9ASMN1; SMN2KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6783812-B2 USEFUL IN THE MANUFACTURE OF OPTICAL DEVICES; STABILITY DISPLAYTECH, INC. 2004-08-31 US disclosed
US-20020130299-A1 Alkyl silane liquid crystal compounds CITIZEN FINEDEVICE CO., LTD. (JP) 2002-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020130299-A1 Alkyl silane liquid crystal compounds SMURF1, SMURF2, DSTN NPC1 2373/4885RAB9A 3181/4885SMN1; SMN2 2052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.